Survival analysis was performed on 113 patients and the following variables were examined: cytoplasmic or nuclear CXCR4 expression, tumor size, lymph node metastasis, hormonal status, c-erbB-2, p53, histological grade, and nitrotyrosine formation. The gene discussed is CXCR4; the disease is metastatic malignant neoplasm in the lymph nodes.